INTRODUCTION
S tatins,alsoknownas3-hydroxy-3-methylglutaryl co-enzymeA(HMG-CoA)reductaseinhibitors,are commonlyusedascholesterol-loweringdrugsinpatients withhyperlipidemia.Currentliteratureshowstheefficacyof statinsinreductionoftheincidenceofcerebrovascularand cardiovascularevents,uncommittedoftheireffecton cholesterollevels [1] [2] [3] [4] .Duringthepastdecade,evidencehas emergedthatstatinsalsohaveneuroprotectiveeffectsin patientswithseveraldiseasesofthecentralnervoussystem, includingAlzheimer'sdisease(AD),Parkinsondisease(PD), multiplesclerosis (MS),andischemicstroke [5] .Statins upregulateendothelialnitricoxidesynthaseandinhibit induciblenitric oxide synthase,whichmayhave neuroprotectiveeffects [6] [7] .Statinsmayalsoattenuatethe inflammatorycytokineresponsesthataccompanycerebral ischemiaandpossess antioxidantpropertiesthatmay ameliorateischemicoxidativestressesinthebrain [7] [8] [9] .The preservationofendothelialnitricoxidesynthaseactivityin cerebralvasculaturemaybeimportantinmaintainingblood flowandlimitingneuronalloss. Inglaucoma,retinalganglioncell(RGC)deathandatrophy ofopticnerveleadtoprogressivevisionlossandvisual dysfunction.Elevatedintraocularpressure(IOP)isamajor riskfactorforglaucoma.Manypatients,however,continueto losevisiondespiteadequateIOPcontrol.Thisevidence suggeststhatothermechanismsthanIOPalsocontributeto diseaseprogression. Theresultsofthestudiesinvestigatingthebeneficialeffectof statinsinglaucomapatientsareinconsistent [10] [11] .Whilesome studiessuggestthatstatinsmayhaveprotectiveeffect [12] [13] , somedonotsupportthiseffect [10] [11] .Stein [14] [17] .
TUNEL staining Apoptoticcellsweredetectedby
TdT-dUTPterminalnickend-labelling(TUNEL)ineachhalf ofretinas.TUNELwasperformedaspreviouslydefined usingtheApopTagPeroxidaseInSituApoptosisdetectionkit (S7110,Millipore,Inc.,Temecula,CA,USA),followingthe manufacturer'sinstructions.Peroxidasesubstrate3, 3-diaminobenzidinewasusedtostainforapoptoticcells. Methylgreen(0.5%)wasusedasanuclearstain.TUNEL positivecellswereobservedunderalightmicroscope (Olympus,BX51,Japan).ThenumbersofTUNEL-positive cellsintheRGClayerperretinawerecountedinthreeor moresections.Themeancellcountsofthesesectionswere usedtosettheproportionofcellsundergoingapoptosisfor eachlayerofeachparticulareye [17] . .Itis alsorelativelyhydrophilicanddisplaysapotentialprotective effectincerebralischemiainmice [19] ,ifadministeredfor10d beforetheischemicinsult. Cauterizationof2ormoreextraocularveinsoftherathas beendescribedtoincreaseIOP [15] .ThemeanIOPincrease correlateswiththenumberofcauterizedveins.Most researcherstypicallyoccludedthreeveinsintheirstudies. ThisprocedureinducesapoptoticdeathofRGC,thinningof thenervefiberlayer,cuppingoftheopticdisc,and degenerationoftheopticnerve [20] [21] [22] [23] . Inourexperiment,rosuvastatinhadnoeffectonIOP.The absenceofdecreasedIOPinoralrosuvastatin-treatedanimals supportstheideathatinsteadofreducingIOP,ithasadirect neuroprotectiveactiononRGCs. Inourstudy,percentageofRGClossisingeneralagreement withthosereportedbyothersusingsimilarmodels [20] [21] [22] [23] .We observed2.5%lossinRGCsinglaucomatouseyesoforally treatedanimals;comparedto23.9%lossincontroleyes (untreated) [24] [25] .Hypertrophic morphologyandincreasedGFAPimmunostaininginretinal astrocytesandM俟llercellsinglaucomatouseyesindicatethat activationofretinalmacroglialcellshasoccurredinthe glaucomatousretina [24] [25] .Inourstudy,aftertheinductionof IOPelevation,cauterizedeyesshowedasignificantincrease inGFAPexpression2wkaftertheinjury.BeforeIOP elevation,GFAPimmunoreactivitymightbeconfinedto astrocytesandtheendfeetofM 俟 llercellsattheinner limitingmembrane,butafterIOPelevation,itmightextend totheouternuclearlayer.IncreasedGFAPexpressionmight showglialcellactivationaftertheIOPelevation.However, inthecurrentstudy,GFAPimmunoreactivitywasfoundtobe decreasedineyesofanimalsreceivedoralrosuvastatin treatmentcomparedtothoseofuntreatedcauterizedeyes (group5). Kretz [26] demonstratedthatintravitrealsimvastatin injectioninducedheatshockproteinexpressionin axotomizedRGCs,protectedneuronsfromapoptoticdeath andenhancedRGCsurvivalearlyandevendelayedafter opticnerveinjury.However,wehavenotbeenableto demonstratethebeneficaleffectsofintravitrealrosuvastatin inourstudy.Onthecontrary,wehavefoundasignificant associationbetweentheintravitrealrosuvastatininjectionand RGCloss.Rosuvastatinexhibitedspecificityforuptakeinto theliverinrats [27] astheliveristhetargetorgan,thismay translate intoanadvantageousclinicalcharacteristic. [28] .Thesemightexplainwhy intravitreal rosuvastatindecreasedRGCsurvivalinourstudywhereas somereportssuggestthatintravitrealsimvastatinmightbe neuroprotective. Sicard [29] evaluatedinfluenceofrosuvastatinon the NAD(P)Hoxidaseactivityintheretinaand electroretinographic responseofgeneticallyhypertensive rats.Theyconcludedthat;rosuvastatintherapycould decreaseproductionofretinalsuperoxideanionthroughthe inhibitionofNAD(P)Hoxidaseactivity,independentlyofa reductioninplasmaandtissuecholesterollevels,butmight notbesufficienttorestoreretinalfunction. Thereareconflictingfindingsintheliteratureregarding whetherstatinsmaybebeneficialinpatientswithglaucoma. Acase-controlstudybyMcGwin [12] demonstratedthat individualsprescribedstatinsfor>24mohad40%reduced oddsofdevelopingOAG.AprospectivestudybyLeung [13] demonstratedthatstatinusewasassociatedwith visualfieldstabilizationover3yamongpatientswithnormal tensionglaucoma.DeCastro [30] showedthatstatinuse slowedglaucomatouschangestotheopticnerveandnerve fiberlayeronconfocalscanninglaserophthalmoscopy.Ina recentretrospectivelongitudinalcohortanalysisbyStein [14] statinusewasassociatedwithasignificantreduction intheriskofOAGamongpersonswithhyperlipidemia.A largecase-controlstudybyOwen [10] 
